To The Editor : We have read with interest the article by Juan et al[1][1] in the July 1, 1997 issue of Blood . The study follows a previously published paper in Blood[2][2] from the same laboratory. Both papers focus on the biology of flt3 ligand (FL). In the Juan study, a retrovirus was
No takes yet. Share an insight, caveat, or question.
Douglas E. Williams (1997) studied this question.